FDA: Arrhythmia Risk With Lamotrigine May Be Class Effect

(MedPage Today) -- The FDA on Wednesday updated its warning about potential increased arrhythmia risk in people with cardiac disease who are taking the seizure and mental health drug lamotrigine (Lamictal) with new data.
In October 2020, the FDA...